![CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design - Moscoso - Alzheimer's & Dementia - Wiley Online Library CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design - Moscoso - Alzheimer's & Dementia - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/2ef82132-204b-472f-ba0f-cbebe81847b0/alz.v18.8.cover.jpg)
CSF biomarkers and plasma p‐tau181 as predictors of longitudinal tau accumulation: Implications for clinical trial design - Moscoso - Alzheimer's & Dementia - Wiley Online Library
![Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy | Neurology Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy | Neurology](https://n.neurology.org/sites/default/files/highwire/neurology/97/12.cover-source.jpg)
Associations of Fully Automated CSF and Novel Plasma Biomarkers With Alzheimer Disease Neuropathology at Autopsy | Neurology
![Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease | Nature Communications Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-30875-7/MediaObjects/41467_2022_30875_Fig1_HTML.png)
Comprehensive genetic analysis of the human lipidome identifies loci associated with lipid homeostasis with links to coronary artery disease | Nature Communications
![Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative - Veitch - 2019 - Alzheimer's & Dementia - Wiley Online Library Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative - Veitch - 2019 - Alzheimer's & Dementia - Wiley Online Library](https://alz-journals.onlinelibrary.wiley.com/cms/asset/583cc695-f092-4d06-bc3a-2e077276467e/alzjjalz201808005-fig-0009-m.jpg)
Understanding disease progression and improving Alzheimer's disease clinical trials: Recent highlights from the Alzheimer's Disease Neuroimaging Initiative - Veitch - 2019 - Alzheimer's & Dementia - Wiley Online Library
![The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk | Science Translational Medicine The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk | Science Translational Medicine](https://www.science.org/cms/10.1126/scitranslmed.aau2291/asset/f0396938-5d55-46e8-a4c1-16fdc254bea2/assets/graphic/aau2291-f1.jpeg)
The MS4A gene cluster is a key modulator of soluble TREM2 and Alzheimer's disease risk | Science Translational Medicine
![Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study - The Lancet Neurology Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study - The Lancet Neurology](https://www.thelancet.com/cms/attachment/8326bb5a-3f66-4452-827d-b9c873e05e82/gr1_lrg.jpg)
Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study - The Lancet Neurology
![Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease | Communications Biology Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease | Communications Biology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs42003-022-04011-6/MediaObjects/42003_2022_4011_Fig1_HTML.png)
Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease | Communications Biology
![CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease | Scientific Reports CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-20324-2/MediaObjects/41598_2022_20324_Fig1_HTML.png)
CSF GAP-43 as a biomarker of synaptic dysfunction is associated with tau pathology in Alzheimer's disease | Scientific Reports
![Frontiers | Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease Frontiers | Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease](https://www.frontiersin.org/files/Articles/463671/fncom-13-00054-HTML/image_m/fncom-13-00054-g001.jpg)
Frontiers | Linking Molecular Pathways and Large-Scale Computational Modeling to Assess Candidate Disease Mechanisms and Pharmacodynamics in Alzheimer's Disease
![Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation | EMBO Molecular Medicine Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation | EMBO Molecular Medicine](https://www.embopress.org/cms/asset/4291317c-70eb-435e-ae39-21042055fff5/emmm202012308-abs-0001-m.jpg)
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta‐amyloid accumulation | EMBO Molecular Medicine
![APOE-ε4 modulates the association among plasma Aβ42/Aβ40, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults | Translational Psychiatry APOE-ε4 modulates the association among plasma Aβ42/Aβ40, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults | Translational Psychiatry](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41398-022-01899-w/MediaObjects/41398_2022_1899_Fig1_HTML.png)
APOE-ε4 modulates the association among plasma Aβ42/Aβ40, vascular diseases, neurodegeneration and cognitive decline in non-demented elderly adults | Translational Psychiatry
![Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET | Science Translational Medicine Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET | Science Translational Medicine](https://www.science.org/cms/asset/e2493646-edd3-4421-ab74-43b13ae35f35/aau5732-f1.gif)
Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET | Science Translational Medicine
Effect of prolonged phenytoin administration on rat brain gene expression assessed by DNA microarrays
![Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease | Nature Communications Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-020-19473-7/MediaObjects/41467_2020_19473_Fig1_HTML.png)
Concordant peripheral lipidome signatures in two large clinical studies of Alzheimer's disease | Nature Communications
Multiomics integrative analysis identifies APOE allele-specific blood biomarkers associated to Alzheimer's disease etiopathogenesis | Aging
![Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer's disease | eLife Integrated transcriptomic and neuroimaging brain model decodes biological mechanisms in aging and Alzheimer's disease | eLife](https://iiif.elifesciences.org/lax/62589%2Felife-62589-fig4-v1.tif/full/1500,/0/default.jpg)